Evaluation of clinical and laborator y parameters in a patient with recurrent myocardial infarctions

Today, the problem of drug-drug interactions is relevant in clinical practice, since such interactions often lead to an undesirable pharmacological effect. This problem is encountered in many areas of medicine, including cardiology practice.

Authors

Publication Details

Journal
Glavvrač (Chief Medical Officer)
Published
2025-03-22
DOI
https://doi.org/10.33920/med-03-2504-15
Primary Topic
Acute Myocardial Infarction Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of clinical and laborator y parameters in a patient with recurrent myocardial infarctions

K Georgieva, К. А. Михайлов, Z.R. Nizametdinova
Glavvrač (Chief Medical Officer)
Acute Myocardial Infarction Research
article

Evaluation of clinical and laborator y parameters in a patient with recurrent myocardial infarctions

K Georgieva, К. А. Михайлов, Z.R. Nizametdinova
article en

Abstract

Today, the problem of drug-drug interactions is relevant in clinical practice, since such interactions often lead to an undesirable pharmacological effect. This problem is encountered in many areas of medicine, including cardiology practice.

Glavvrač (Chief Medical Officer)(4)
Openalex Percentile: Top 81%
Acute Myocardial Infarction Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Evaluation of clinical and laborator y parameters in a patient with recurrent myocardial infarctions — K Georgieva, К. А. Михайлов, et al. · Glavvrač (Chief Medical Officer) (2025) | TGRS Research Map | TGRS